暂无推荐供应商。我要出现这里
化源商城直购
CDK6/cyclinD1:905 nM (IC50)
CDK4/cyclinD1
[1]. Kai Yuan, et al. Discovery of novel and orally bioavailable CDK 4/6 inhibitors with high kinome selectivity, low toxicity and long-acting stability for the treatment of multiple myeloma. Eur J Med Chem. 2022 Jan 15;228:114024.